BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1769495)

  • 1. [Criteria of differential diagnosis of chronic myeloproliferative diseases].
    Shardakov VI; Kopaneva TG; Dem'ianova VT
    Gematol Transfuziol; 1991 Jun; 36(6):3-4. PubMed ID: 1769495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract]   [Full Text] [Related]  

  • 3. [Status of nonspecific defense factors in patients with chronic myeloproliferative diseases].
    Shardakov VI; Kopaneva TG; Shuliat'eva TN; Kuznetsova NN; Nikiforova TV
    Gematol Transfuziol; 1990 Jun; 35(6):22-4. PubMed ID: 2394364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophilic myelofibrosis presenting as Philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia.
    Stewart K; Carstairs KC; Dubé ID; Keating A
    Am J Hematol; 1990 May; 34(1):59-63. PubMed ID: 2327406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of proper-myl on humoral interactions between activated lymphocytes and neutrophils in patients with myeloproliferative diseases].
    Guseva SA
    Antibiot Khimioter; 1991 Jan; 36(1):35-7. PubMed ID: 2053821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
    Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
    Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis of the development of fibroreticular tissue in patients with chronic myeloleukemia].
    Shardakov VI; Kopaneva TG; Minakov VN; Fedorovskaia NA
    Gematol Transfuziol; 1988 Aug; 33(8):28-9. PubMed ID: 3192052
    [No Abstract]   [Full Text] [Related]  

  • 8. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH; Gulati GL; Ashton JK
    Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
    Binotto G; Bertorelle R; Bonaldi L; Frison L; Vianello F; Pizzi M
    Int J Surg Pathol; 2019 Oct; 27(7):771-772. PubMed ID: 30813806
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis.
    Jallades L; Hayette S; Tigaud I; Johnston A; Coiffier B; Magaud JP; Ffrench M
    Leuk Res; 2008 Oct; 32(10):1608-10. PubMed ID: 18448166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune complexes in myeloproliferative disorders.
    Lewis CM; Pegrum GD
    Lancet; 1977 Dec; 2(8049):1151-3. PubMed ID: 73061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.
    Kim HY; Park S; Kim SH; Kim HJ
    Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neutrophil alkaline phosphatase score].
    Nakamura Y; Waga K; Mitani K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular genetic evaluation of myeloproliferative neoplasms.
    Azzato EM; Bagg A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphoid Leukemia during Various Phases of Diseases.
    Dolgikh TY; Domnikova NP; Tornuev YV; Vinogradova EV; Krinitsyna YM
    Bull Exp Biol Med; 2017 Feb; 162(4):483-487. PubMed ID: 28239786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of chronic myeloproliferative disorders].
    Kimura A
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):507-12. PubMed ID: 9577584
    [No Abstract]   [Full Text] [Related]  

  • 19. [An unusual chronic myeloproliferation].
    Kolesková E; Háber J; Klener P
    Vnitr Lek; 1989 May; 35(5):489-92. PubMed ID: 2763484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of massive splenomegaly. Agnogenic myeloid metaplasia versus chronic granulocytic leukemia.
    LINMAN JW
    Med Clin North Am; 1962 Jan; 46():49-62. PubMed ID: 14465617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.